Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $242.20 million. The enterprise value is $306.37 million.
Important Dates
The last earnings date was Tuesday, March 4, 2025, before market open.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 65.81 million shares outstanding. The number of shares has increased by 10.73% in one year.
| Current Share Class | 65.81M |
| Shares Outstanding | 65.81M |
| Shares Change (YoY) | +10.73% |
| Shares Change (QoQ) | +21.77% |
| Owned by Insiders (%) | 6.48% |
| Owned by Institutions (%) | 11.50% |
| Float | 34.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| Forward PS | 2.06 |
| PB Ratio | 7.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 2.60.
| Current Ratio | 1.86 |
| Quick Ratio | 1.44 |
| Debt / Equity | 2.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.66 |
Financial Efficiency
Return on equity (ROE) is -132.53% and return on invested capital (ROIC) is -20.11%.
| Return on Equity (ROE) | -132.53% |
| Return on Assets (ROA) | -16.54% |
| Return on Invested Capital (ROIC) | -20.11% |
| Return on Capital Employed (ROCE) | -30.98% |
| Revenue Per Employee | $368,916 |
| Profits Per Employee | -$215,310 |
| Employee Count | 203 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 3.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.69% in the last 52 weeks. The beta is 2.07, so Neuronetics's price volatility has been higher than the market average.
| Beta (5Y) | 2.07 |
| 52-Week Price Change | -22.69% |
| 50-Day Moving Average | 4.01 |
| 200-Day Moving Average | 1.96 |
| Relative Strength Index (RSI) | 39.38 |
| Average Volume (20 Days) | 1,533,440 |
Short Selling Information
The latest short interest is 2.78 million, so 4.23% of the outstanding shares have been sold short.
| Short Interest | 2.78M |
| Short Previous Month | 1.99M |
| Short % of Shares Out | 4.23% |
| Short % of Float | 8.03% |
| Short Ratio (days to cover) | 1.43 |
Income Statement
In the last 12 months, Neuronetics had revenue of $74.89 million and -$43.71 million in losses. Loss per share was -$1.38.
| Revenue | 74.89M |
| Gross Profit | 54.76M |
| Operating Income | -33.96M |
| Pretax Income | -27.54M |
| Net Income | -43.71M |
| EBITDA | -31.98M |
| EBIT | -33.96M |
| Loss Per Share | -$1.38 |
Full Income StatementBalance Sheet
The company has $18.46 million in cash and $82.63 million in debt, giving a net cash position of -$64.17 million or -$0.98 per share.
| Cash & Cash Equivalents | 18.46M |
| Total Debt | 82.63M |
| Net Cash | -64.17M |
| Net Cash Per Share | -$0.98 |
| Equity (Book Value) | 31.80M |
| Book Value Per Share | 0.50 |
| Working Capital | 26.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$31.00 million and capital expenditures -$1.47 million, giving a free cash flow of -$32.46 million.
| Operating Cash Flow | -31.00M |
| Capital Expenditures | -1.47M |
| Free Cash Flow | -32.46M |
| FCF Per Share | -$0.49 |
Full Cash Flow StatementMargins
Gross margin is 73.12%, with operating and profit margins of -45.35% and -58.36%.
| Gross Margin | 73.12% |
| Operating Margin | -45.35% |
| Pretax Margin | -58.39% |
| Profit Margin | -58.36% |
| EBITDA Margin | -42.70% |
| EBIT Margin | -45.35% |
| FCF Margin | n/a |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.73% |
| Shareholder Yield | -10.73% |
| Earnings Yield | -18.05% |
| FCF Yield | -13.40% |
Analyst Forecast
The average price target for Neuronetics is $6.00, which is 63.04% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 63.04% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 29.09% |
| EPS Growth Forecast (5Y) | -65.04% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -3.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.84 |
| Piotroski F-Score | 2 |